Naoya Sato

10PUBLICATIONS
21CO-AUTHORS
Epidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Numerical modelling and mechanical characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 18, 2026
Nationwide Real-World Modeling of Surgical Outcomes in Elderly Patients: Incorporating Geriatric-Specific Risk Factors Into Prediction of Mortality and Morbidity.

|Jan 07, 2026
Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance.

Amar Singh, Adam Herman, Devanjan Dey

|Dec 11, 2025
MicroRNA-1 Suppresses Tumor Progression and UHRF1 Expression in Cholangiocarcinoma.

Makoto Muto, Teruhide Ishigame, Takashi Kimura

|Jul 03, 2024
Predicting surgical outcomes of acute diffuse peritonitis: Updated risk models based on real-world clinical data.

Naoya Sato, Shinya Hirakawa, Shigeru Marubashi

|Aug 14, 2023
Reply to the Letter to the Editor: Oncological benefit of anatomic resection for patients with hepatocellular carcinoma.

Naoya Sato, Shigeru Marubashi

|Jan 20, 2023
Achieving clinically optimal balance between accuracy and simplicity of a formula for manual use: Development of a simple formula for estimating liver graft weight with donor anthropometrics.

Nao Ichihara, Naoya Sato, Shigeru Marubashi

Pageof 2

Frequent Collaborators

2 joint publications

Shigeru Marubashi

2 joint publications

Yoshihiro Kakeji

1 joint publications

Nao Ichihara

1 joint publications

Taro Oshikiri